Search Results - "Lana, Susan"

Multi-omics approach identifies germline regulatory variants associated with hematopoietic malignancies in retriever dog breeds by Evans, Jacquelyn M, Parker, Heidi G, Rutteman, Gerard R, Plassais, Jocelyn, Grinwis, Guy C M, Harris, Alexander C, Lana, Susan E, Ostrander, Elaine A

“…Histiocytic sarcoma is an aggressive hematopoietic malignancy of mature tissue histiocytes with a poorly understood etiology in humans. A histologically and…”
Get full text

Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions by Das, Sunetra, Idate, Rupa, Lana, Susan E., Regan, Daniel P., Duval, Dawn L.

“…Soft tissue sarcomas (STS) are a heterogenous group of mesenchymal tumors representing over 50 distinct types with overlapping histological features and…”
Get full text

Author Correction: Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions by Das, Sunetra, Idate, Rupa, Lana, Susan E., Regan, Daniel P., Duval, Dawn L.

Get full text

Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression by Paoloni, Melissa, Davis, Sean, Lana, Susan, Withrow, Stephen, Sangiorgi, Luca, Picci, Piero, Hewitt, Stephen, Triche, Timothy, Meltzer, Paul, Khanna, Chand

“…Pulmonary metastasis continues to be the most common cause of death in osteosarcoma. Indeed, the 5-year survival for newly diagnosed osteosarcoma patients has…”
Get full text

Molecular landscape of canine soft tissue sarcoma by Das, Sunetra, Idate, Rupa, Regan, Daniel P., Lana, Susan E., Duval, Dawn L.

“…Canine soft tissue sarcomas (STS) are a heterogenous group of malignant tumors arising from mesenchymal cells of soft tissues. This simplified collective of…”
Get full text

Pathology in Practice by Kline, Kyle, Dolan, Christopher, Young, Brian, Lana, Susan E, Vap, Linda, Dubielzig, Richard, Teixeira, Leandro, Henriksen, Michala de Linde

“…In collaboration with the American College of Veterinary Pathologists…”
Get full text

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs by LeBlanc, Amy K, Mazcko, Christina N, Cherukuri, Aswini, Berger, Erika P, Kisseberth, William C, Brown, Megan E, Lana, Susan E, Weishaar, Kristen, Flesner, Brian K, Bryan, Jeffrey N, Vail, David M, Burton, Jenna H, Willcox, Jennifer L, Mutsaers, Anthony J, Woods, J Paul, Northrup, Nicole C, Saba, Corey, Curran, Kaitlin M, Leeper, Haley, Wilson-Robles, Heather, Wustefeld-Janssens, Brandan G, Lindley, Stephanie, Smith, Annette N, Dervisis, Nikolaos, Klahn, Shawna, Higginbotham, Mary Lynn, Wouda, Raelene M, Krick, Erika, Mahoney, Jennifer A, London, Cheryl A, Barber, Lisa G, Balkman, Cheryl E, McCleary-Wheeler, Angela L, Suter, Steven E, Martin, Olya, Borgatti, Antonella, Burgess, Kristine, Childress, Michael O, Fidel, Janean L, Allstadt, Sara D, Gustafson, Daniel L, Selmic, Laura E, Khanna, Chand, Fan, Timothy M

“…The mTOR pathway has been identified as a key nutrient signaling hub that participates in metastatic progression of high-grade osteosarcoma. Inhibition of mTOR…”
Get full text

Colorado State University, Pet Hospice Program by Gore, Maria, Lana, Susan E, Bishop, Gail A

“…Serving clients since 2004, Colorado State University's Veterinary Teaching Hospital is the first and only program to offer a student-run pet hospice program…”
Get more information

Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer by Wang, Jin, Wang, Tianfang, Sun, Yanfang, Feng, Yuan, Kisseberth, William C, Henry, Carolyn J, Mok, Irene, Lana, Susan E, Dobbin, Kevin, Northrup, Nicole, Howerth, Elizabeth W, Zhao, Shaying

“…Spontaneous tumors in pet dogs represent a valuable but undercharacterized cancer model. To better use this resource, we performed an initial global comparison…”
Get full text

Canine salivary gland carcinoma treated with stereotactic body radiation therapy: a retrospective case series by Gualtieri, Patricia, Martin, Tiffany, Leary, Del, Lana, Susan E, LaRue, Susan M, Boss, Mary-Keara

“…The aim of this study was to describe the therapeutic outcomes of dogs with locally advanced salivary gland carcinomas (SGC) following stereotactic body…”
Get full text

Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats by Reczynska, Alicja I., LaRue, Susan M., Boss, Mary‐Keara, Lee, Ber‐In, Leary, Del, Pohlmann, Kelsey, Griffin, Lynn, Lana, Susan, Wormhoudt Martin, Tiffany

“…Background The safety and efficacy of stereotactic body radiation therapy (SBRT) in the treatment of localized nasal lymphoma in cats has not been described…”
Get full text

Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma by Paoloni, Melissa, Mazcko, Christina, Selting, Kimberly, Lana, Susan, Barber, Lisa, Phillips, Jeffrey, Skorupski, Katherine, Vail, David, Wilson, Heather, Biller, Barbara, Avery, Anne, Kiupel, Matti, LeBlanc, Amy, Bernhardt, Anna, Brunkhorst, Beatrice, Tighe, Robert, Khanna, Chand

“…Interleukin (IL)-12 is a pro-inflammatory cytokine that mediates T-helper type 1 responses and cytotoxic T-cell activation, contributing to its utility as…”
Get full text

Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma by Das, Sunetra, Idate, Rupa, Regan, Daniel P., Fowles, Jared S., Lana, Susan E., Thamm, Douglas H., Gustafson, Daniel L., Duval, Dawn L.

“…Osteosarcoma affects about 2.8% of dogs with cancer, with a one-year survival rate of approximately 45%. The purpose of this study was to characterize mutation…”
Get full text

Characterizing the molecular and immune landscape of canine bladder cancer by Cronise, Kathryn E., Das, Sunetra, Hernandez, Belen G., Regan, Daniel P., Dailey, Deanna D., McGeachan, Robert I., Lana, Susan E., Page, Rodney L., Gustafson, Daniel L., Duval, Dawn L.

“…Transitional cell carcinoma (TCC), also known as urothelial carcinoma, is the most common bladder cancer in humans and dogs. Approximately one‐quarter of human…”
Get full text

Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B‐cell lymphoma treated with a 19‐week CHOP protocol by Wolf‐Ringwall, Amber, Lopez, Lynelle, Elmslie, Robyn, Fowler, Brooke, Lori, Janet, Sfiligoi, Gabriella, Skope, Anne, Arnold, Erin, Hughes, Kelly L., Thamm, Douglas H., Ehrhart, E. J., Avery, Anne C., Lana, Susan E.

“…Canine B‐cell lymphoma is a clinically heterogenous disease; however, it is generally treated as a single disease entity. The purpose of this clinical trial…”
Get full text

Intensity of perioperative analgesia but not pre‐treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma by Nolan, Michael W., Uzan, Olivia C., Green, Noah A., Lana, Susan E., Lascelles, B. Duncan X.

“…The purpose of this bi‐institutional retrospective study was to determine whether, in dogs treated with limb amputation and adjunctive chemotherapy for…”
Get full text

Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamide by Stroda, Katherine A, Murphy, Jacqueline D, Hansen, Ryan J, Brownlee, Lisa, Atencio, Elizabeth A, Gustafson, Daniel L, Lana, Susan E

“…OBJECTIVE To characterize pharmacokinetics of cyclophosphamide and 4-hydoxycyclophosphamide (4-OHCP) in the plasma of healthy cats after oral, IV, and IP…”
Get full text

An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs by Frankhouse, Kari A., Rout, Emily D., Hughes, Kelly L., Labadie, Julia D., Yoshimoto, Janna A., Lana, Susan E., Avery, Paul R., Avery, Anne C.

“…T‐cell leukemia/lymphoma accounts for roughly 30% of all types of lymphoproliferative neoplasia in dogs. Two forms of T‐cell lymphoma (T‐zone and peripheral…”
Get full text

A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model by Saba, Corey, Paoloni, Melissa, Mazcko, Christina, Kisseberth, William, Burton, Jenna H, Smith, Annette, Wilson-Robles, Heather, Allstadt, Sara, Vail, David, Henry, Carolyn, Lana, Susan, Ehrhart, E J, Charles, Brad, Kent, Michael, Lawrence, Jessica, Burgess, Kristine, Borgatti, Antonella, Suter, Steve, Woods, Paul, Gordon, Ira, Vrignaud, Patricia, Khanna, Chand, LeBlanc, Amy K

“…Development of iniparib as an anti-cancer agent was hindered in part by lingering questions regarding its mechanism of action, the activity of its metabolites,…”
Get full text

Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials by Paoloni, Melissa, Webb, Craig, Mazcko, Christina, Cherba, David, Hendricks, William, Lana, Susan, Ehrhart, E J, Charles, Brad, Fehling, Heather, Kumar, Leena, Vail, David, Henson, Michael, Childress, Michael, Kitchell, Barbara, Kingsley, Christopher, Kim, Seungchan, Neff, Mark, Davis, Barbara, Khanna, Chand, Trent, Jeffrey

“…Molecularly-guided trials (i.e. PMed) now seek to aid clinical decision-making by matching cancer targets with therapeutic options. Progress has been hampered…”
Get full text